Lead generation and optimization based on protein-ligand complementarity.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Koji OgataShoshana J Wodak

Abstract

This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH(3), NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chem...Continue Reading

References

Dec 1, 1992·Journal of Computer-aided Molecular Design·H J Böhm
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T OoiH A Scheraga
Feb 3, 1995·Journal of Medicinal Chemistry·D K GehlhaarS T Freer
Dec 1, 1995·Current Opinion in Biotechnology·G Jones, P Willett
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
May 29, 2002·Bioorganic & Medicinal Chemistry Letters·Lars NaerumPreben H Olesen
Feb 5, 2003·Drug Discovery Today·Gilbert M Rishton
Mar 15, 2003·Journal of Molecular Modeling·S F Badreddin AbolmaaliAndreas Zell
Oct 17, 2003·Journal of Medicinal Chemistry·Alejandra TrejoDavid M Goldstein
Jan 23, 2004·Journal of Medicinal Chemistry·David G LloydPhilip M Dean
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Nov 30, 2004·Journal of Medicinal Chemistry·Jeremy L JenkinsJohn W Davies
Sep 27, 2005·Journal of Chemical Information and Modeling·Marie M AhlströmIsmael Zamora
Dec 13, 2005·Bioorganic & Medicinal Chemistry Letters·Kazuto YamazakiMasaharu Kanaoka
Feb 16, 2006·Drug Discovery Today·Volker Schnecke, Jonas Boström
Mar 28, 2006·Journal of Chemical Information and Modeling·Edward J BarkerValerie J Gillet
Jul 25, 2006·Journal of Molecular Graphics & Modelling·Zsolt ZsoldosA Peter Johnson
Aug 8, 2006·ChemMedChem·Steffen Renner, Gisbert Schneider
Jan 5, 2007·Journal of Computer-aided Molecular Design·Ravindra G KulkarniG Narahari Sastry
Feb 16, 2007·Journal of Medicinal Chemistry·Alex M AronovXiaoling Xie
Feb 28, 2007·Journal of Medicinal Chemistry·Christian PeiferStefan Laufer
Apr 12, 2007·Journal of Medicinal Chemistry·Emanuele CarosatiMassimo Baroni
May 11, 2007·Journal of Medicinal Chemistry·Rikke BergmannIsmael Zamora
Sep 4, 2008·Journal of Chemical Information and Modeling·Pramod C Nair, M Elizabeth Sobhia
Dec 23, 2009·Combinatorial Chemistry & High Throughput Screening·Marianne A Grant

❮ Previous
Next ❯

Citations

May 28, 2021·RSC Medicinal Chemistry·Jeffrey D St DenisDavid C Rees

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

GAFF
DOCK
GOLD
eHiTS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.